Blessing M Fubara

Array ( [id] => 11662551 [patent_doc_number] => 20170151257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-01 [patent_title] => 'METHOD FOR THE TREATMENT OF DRAVET SYNDROME' [patent_app_type] => utility [patent_app_number] => 15/429641 [patent_app_country] => US [patent_app_date] => 2017-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3023 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15429641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11662488 [patent_doc_number] => 20170151194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-01 [patent_title] => 'METHOD FOR THE TREATMENT OF DRAVET SYNDROME' [patent_app_type] => utility [patent_app_number] => 15/429650 [patent_app_country] => US [patent_app_date] => 2017-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3023 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15429650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11662507 [patent_doc_number] => 20170151213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-01 [patent_title] => 'METHOD FOR THE TREATMENT OF DRAVET SYNDROME' [patent_app_type] => utility [patent_app_number] => 15/429516 [patent_app_country] => US [patent_app_date] => 2017-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3018 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15429516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15130011 [patent_doc_number] => 10478442 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-19 [patent_title] => Method for the treatment of Dravet Syndrome [patent_app_type] => utility [patent_app_number] => 15/429646 [patent_app_country] => US [patent_app_date] => 2017-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2823 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15429646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11662552 [patent_doc_number] => 20170151259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-01 [patent_title] => 'METHOD FOR THE TREATMENT OF DRAVET SYNDROME' [patent_app_type] => utility [patent_app_number] => 15/429506 [patent_app_country] => US [patent_app_date] => 2017-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3017 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15429506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13840419 [patent_doc_number] => 20190023694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-24 [patent_title] => BROAD SPECTRUM ANTIBACTERIAL ACTIVITY OF NOVEL BISBENZIMIDAZOLES TARGETING TOPOISOMERASE IA AND THE SYNERGISTIC COMPOSITION OF BISBENZIMIDAZOLE WITH EFFLUX PUMP INHIBITORS AGAINST PATHOGENIC BACTERIA [patent_app_type] => utility [patent_app_number] => 16/072018 [patent_app_country] => US [patent_app_date] => 2017-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5759 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16072018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11742821 [patent_doc_number] => 20170196893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-13 [patent_title] => 'TREATMENT OF INFLAMMATORY DEMYELINATING DISEASE WITH AGONISTS OF FARNESOID X RECEPTOR' [patent_app_type] => utility [patent_app_number] => 15/400903 [patent_app_country] => US [patent_app_date] => 2017-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10487 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15400903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11713527 [patent_doc_number] => 20170182026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-29 [patent_title] => 'Anti-Metastasis Treatment of Melanoma' [patent_app_type] => utility [patent_app_number] => 15/391516 [patent_app_country] => US [patent_app_date] => 2016-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11219 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15391516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11555163 [patent_doc_number] => 20170101409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-13 [patent_title] => 'INDOLIN-2-ONE OR PYRROLO-PYRIDIN-2-ONE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 15/389275 [patent_app_country] => US [patent_app_date] => 2016-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28092 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15389275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11704492 [patent_doc_number] => 20170172991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-22 [patent_title] => 'IMAGE GUIDED THERAPY FOR CANCER' [patent_app_type] => utility [patent_app_number] => 15/383983 [patent_app_country] => US [patent_app_date] => 2016-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8576 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15383983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11704461 [patent_doc_number] => 20170172960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-22 [patent_title] => 'PHARMACEUTICAL FORMULATIONS FOR TREATING KIDNEY STONES AND METHODS FOR FABRICATING AND USING THEREOF' [patent_app_type] => utility [patent_app_number] => 15/383211 [patent_app_country] => US [patent_app_date] => 2016-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3517 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15383211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17118715 [patent_doc_number] => 11129824 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-28 [patent_title] => Small molecules for inhibiting chemokine activity and/or cancer cells growth [patent_app_type] => utility [patent_app_number] => 16/063279 [patent_app_country] => US [patent_app_date] => 2016-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 73 [patent_no_of_words] => 30060 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13504549 [patent_doc_number] => 20180303817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-25 [patent_title] => THERAPEUTIC AGENT FOR BREAST CANCER [patent_app_type] => utility [patent_app_number] => 15/771193 [patent_app_country] => US [patent_app_date] => 2016-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1791 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15771193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11528677 [patent_doc_number] => 20170088655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-30 [patent_title] => 'COPOLYMERS CONTAINING PHOSPHORYLCHOLINE GROUPS AND METHODS OF PREPARING AND USING THE SAME' [patent_app_type] => utility [patent_app_number] => 15/373025 [patent_app_country] => US [patent_app_date] => 2016-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12563 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15373025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13955665 [patent_doc_number] => 20190054176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-21 [patent_title] => COMPOSITIONS OF THERAPEUTIC SUBSTANCES, METHODS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/781639 [patent_app_country] => US [patent_app_date] => 2016-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12304 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15781639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11512864 [patent_doc_number] => 20170079938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-23 [patent_title] => 'Titration of Tapentadol' [patent_app_type] => utility [patent_app_number] => 15/369257 [patent_app_country] => US [patent_app_date] => 2016-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17398 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15369257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13118141 [patent_doc_number] => 10077415 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-18 [patent_title] => Detergents capable of cleaning, bleaching, sanitizing and/or disinfecting textiles including sulfoperoxycarboxylic acids [patent_app_type] => utility [patent_app_number] => 15/368299 [patent_app_country] => US [patent_app_date] => 2016-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 36708 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15368299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13729347 [patent_doc_number] => 20180369141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => MELFLUFEN DOSAGE REGIMENS FOR CANCER [patent_app_type] => utility [patent_app_number] => 15/779609 [patent_app_country] => US [patent_app_date] => 2016-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20939 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15779609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14833157 [patent_doc_number] => 20190274979 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2019-09-12 [patent_title] => USE OF (BENZENESULFONAMIDO)BENZAMIDE COMPOUNDS FOR INHIBITING LIVER FIBROSIS [patent_app_type] => utility [patent_app_number] => 15/779431 [patent_app_country] => US [patent_app_date] => 2016-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15779431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14833157 [patent_doc_number] => 20190274979 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2019-09-12 [patent_title] => USE OF (BENZENESULFONAMIDO)BENZAMIDE COMPOUNDS FOR INHIBITING LIVER FIBROSIS [patent_app_type] => utility [patent_app_number] => 15/779431 [patent_app_country] => US [patent_app_date] => 2016-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15779431 [rel_patent_id] =>[rel_patent_doc_number] =>)